RenovoRx (RNXT) Net Shares Issued and Repurchased (2021 - 2026)
RenovoRx's (RNXT) quarterly Net Shares Issued and Repurchased came in at $12000.0 in Q1 2026, down 76.92% year-over-year from $52000.0 in Q1 2025, and down 99.35% quarter-over-quarter from $1.8 million in Q4 2025.
Analysis
RenovoRx (RNXT) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends
RenovoRx has disclosed Net Shares Issued and Repurchased across 6 years of filings, most recently posting $12000.0 for Q1 2026.
- In Q1 2026, Net Shares Issued and Repurchased fell 76.92% year-over-year to $12000.0; the TTM figure through Mar 2026 stood at $12000.0 (down 76.92% YoY), while the FY2025 annual figure was $1.8 million, up 19.7% from the prior year.
- Net Shares Issued and Repurchased came in at $12000.0 for Q1 2026 at RenovoRx, down from $1.8 million in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $724.9 million in Q4 2022 to a low of $12000.0 in Q1 2026.
- Average Net Shares Issued and Repurchased over 5 years is $81.2 million, with a median of $552096.0 recorded in 2023.
- Year-over-year, Net Shares Issued and Repurchased jumped 232064.09% in 2022 and tumbled 99.92% in 2023.
- Over 5 years, Net Shares Issued and Repurchased stood at $724.9 million in 2022, then plunged by 99.92% to $552096.0 in 2023, then jumped by 179.3% to $1.5 million in 2024, then gained by 19.7% to $1.8 million in 2025, then sank by 99.35% to $12000.0 in 2026.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $12000.0 in Q1 2026, $1.8 million in Q4 2025, and $52000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | RenovoRx | 83.48 Mn | 83.48 Mn | 766,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 1.85 Mn |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 1.54 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 552,096.00 |
| Mar 31, 2023 | 304,325.00 |
| Dec 31, 2022 | 724.94 Mn |
| Mar 31, 2022 | 159,041.00 |
| Dec 31, 2021 | 312,252.00 |